Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FJQL9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,443
Award facts
- Contract value 100% obligated
- $26,443.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,443.48 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose auto-injector pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The SPE2DX prime indefinite delivery contract enables the company to fulfill diverse pharmaceutical requirements across multiple therapeutic domains in support of military healthcare operations worldwide. This specific delivery order for Cosentyx, an immunosuppressive biologic used to treat inflammatory conditions, exemplifies the company's role in supplying specialized pharmaceutical products through DLA's flexible contracting vehicle.
Quick answers
Who was awarded contract SPE2DB25FJQL9?
SPE2DB25FJQL9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FJQL9 worth?
The government has obligated $26,443 on SPE2DB25FJQL9.
Is contract SPE2DB25FJQL9 an order under another contract?
Yes. SPE2DB25FJQL9 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJQL9 competed?
The extent of competition for SPE2DB25FJQL9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award